Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Creatd, Inc.CRTD · Entity 8175 | Director · Chief Executive Officer | June 03, 2022 | June 08, 2022 |
| SurgePays, Inc.SURG · Entity 8365 | Director | July 31, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Creatd, Inc.
Report date June 03, 2022 · Filed June 08, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security | Direct | 195,000 |
Reported balance
After 2022-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-03 · Grant · Acquired 195,000 · Balance 195,000 F1: The options (the "Options") shall be issued on a basis requiring continued employment with the Company and the Company having achieved a minimum of $6 million in net revenues for the 2022 fiscal year. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with (i) 1/3 of the Options, priced at $1.32, vesting on December 31, 2022, (ii) 1/3 of the Options, priced at $1.58, vesting on December 31, 2023, and (iii) the final 1/3 of the Options, priced at $1.90, vesting on December 31, 2024. The restricted stock units do not expire, they either vest or are canceled prior to vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The options (the "Options") shall be issued on a basis requiring continued employment with the Company and the Company having achieved a minimum of $6 million in net revenues for the 2022 fiscal year. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with (i) 1/3 of the Options, priced at $1.32, vesting on December 31, 2022, (ii) 1/3 of the Options, priced at $1.58, vesting on December 31, 2023, and (iii) the final 1/3 of the Options, priced at $1.90, vesting on December 31, 2024. The restricted stock units do not expire, they either vest or are canceled prior to vesting date.
SurgePays, Inc.
Report date July 31, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Shares (Common Stock)SEC Table I · non-derivative | Direct | 406,868 |
Reported balance
After 2026-07-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-31 · Grant · Acquired 315,179 · Balance 406,868 F1: Consists of restricted shares awarded pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, executed on July 31, 2026, by and between SurgePays, Inc. (the "Company") and Ms. Weisberg (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earlier of (i) the date that the director no longer serves as a director of the Company other than as a result of a termination for Cause (as defined in the RSA Agreement); (ii) the occurrence of a Change of Control (as defined in the 2022 Plan); or (iii) June 24, 2029. F2: Includes (i) 2,809 shares held by Ms. Weisberg, and (ii) 88,880 shares issuable pursuant to previous restricted share awards, but does not include 5,000 shares held by Ms. Weisberg's IRA, which shares are deemed to be owed by Ms. Weisberg. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted shares awarded pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, executed on July 31, 2026, by and between SurgePays, Inc. (the "Company") and Ms. Weisberg (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earlier of (i) the date that the director no longer serves as a director of the Company other than as a result of a termination for Cause (as defined in the RSA Agreement); (ii) the occurrence of a Change of Control (as defined in the 2022 Plan); or (iii) June 24, 2029.
F2: Includes (i) 2,809 shares held by Ms. Weisberg, and (ii) 88,880 shares issuable pursuant to previous restricted share awards, but does not include 5,000 shares held by Ms. Weisberg's IRA, which shares are deemed to be owed by Ms. Weisberg.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Sep 16, 2026 20:05 UTC | SurgePays, Inc. SURG · Entity 8365 | GrantRestricted Shares (Common Stock) | 315,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-042900 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,868 F1 · security: Consists of restricted shares awarded pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, executed on July 31, 2026, by and between SurgePays, Inc. (the "Company") and Ms. Weisberg (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earlier of (i) the date that the director no longer serves as a director of the Company other than as a result of a termination for Cause (as defined in the RSA Agreement); (ii) the occurrence of a Change of Control (as defined in the 2022 Plan); or (iii) June 24, 2029. F2 · balance_after: Includes (i) 2,809 shares held by Ms. Weisberg, and (ii) 88,880 shares issuable pursuant to previous restricted share awards, but does not include 5,000 shares held by Ms. Weisberg's IRA, which shares are deemed to be owed by Ms. Weisberg. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:30 UTC | SurgePays, Inc. SURG · Entity 8365 | GrantRestricted Shares (Common Stock) | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-012495 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,809 F1 · shares: These shares were issued pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, dated May 22, 2025, by and between SurgePays, Inc. (the "Company") and Ms. Weisberg (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earliest to occur of (a) the director no longer serves as a director of the Company for any reason (including, but not limited to, upon death or disability that renders the director incapable of providing services to the Company) other than a Termination of Service for Cause (as defined in the RSA Agreement); (b) upon the occurrence of a Change in Control (as defined in the 2022 Plan); or (c) August 8, 2028. Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 21:30 UTC | SurgePays, Inc. SURG · Entity 8365 | PurchaseShares of Common Stock | 3,099 | $1.84 | $5,701.85 |
DisclosureSEC source: 0001493152-24-047622 · ownership.xml · nonDerivative · entry 6 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,809 Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 21:30 UTC | SurgePays, Inc. SURG · Entity 8365 | PurchaseShares of Common Stock | 1,500 | $1.84 | $2,759.70 |
DisclosureSEC source: 0001493152-24-047622 · ownership.xml · nonDerivative · entry 5 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,710 Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 21:30 UTC | SurgePays, Inc. SURG · Entity 8365 | PurchaseShares of Common Stock | 100 | $1.84 | $183.96 |
DisclosureSEC source: 0001493152-24-047622 · ownership.xml · nonDerivative · entry 4 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,210 Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 21:30 UTC | SurgePays, Inc. SURG · Entity 8365 | PurchaseShares of Common Stock | 301 | $1.83 | $550.83 |
DisclosureSEC source: 0001493152-24-047622 · ownership.xml · nonDerivative · entry 3 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,110 Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 21:30 UTC | SurgePays, Inc. SURG · Entity 8365 | PurchaseShares of Common Stock | 0.989 | $1.67 | $1.65 |
DisclosureSEC source: 0001493152-24-047622 · ownership.xml · nonDerivative · entry 2 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,809 F1 · price: Based upon a per share purchase price of $1.6929. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 21:30 UTC | SurgePays, Inc. SURG · Entity 8365 | PurchaseShares of Common Stock | 2,808 | $1.70 | $4,773.60 |
DisclosureSEC source: 0001493152-24-047622 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,808 Read SEC document |
| April 25, 2024 Filed Apr 26, 2024 20:30 UTC | SurgePays, Inc. SURG · Entity 8365 | GrantRestricted Shares (Common Stock) | 14,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-016565 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,880 F1 · shares: These shares were issued pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, dated April 25, 2024, by and between SurgePays, Inc. (the "Company") and Ms. Weisberg (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earliest to occur of (a) the director no longer serves as a director of the Company for any reason (including, but not limited to, upon death or disability that renders the director incapable of providing services to the Company) other than a Termination of Service for Cause (as defined in the RSA Agreement); (b) upon the occurrence of a Change in Control (as defined in the 2022 Plan); or (c) the fourth anniversary of the award date. Read SEC document |
| August 08, 2023 Filed Aug 15, 2023 20:15 UTC | SurgePays, Inc. SURG · Entity 8365 | GrantCommon Stock (Restricted Share Award) | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-028975 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 F1 · kind: These shares were issued to Ms. Weisberg pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, dated August 8, 2023, by and between SurgePays, Inc. (the "Company") and Ms. Weisberg (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earliest to occur of (a) the director no longer serves as a director of the Company for any reason (including, but not limited to, upon death or disability that renders the director incapable of providing services to the Company) other than a Termination of Service for Cause (as defined in the RSA Agreement); (b) upon the occurrence of a Change in Control (as defined in the 2022 Plan); or (c) the fifth anniversary of the award date. Read SEC document |
| June 03, 2022 Filed Jun 8, 2022 00:32 UTC | Creatd, Inc. CRTD · Entity 8175 | GrantStock Options · Derivative | 195,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-031616 · ownership.xml · derivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Underlying: Common Stock · 195,000 shares Expires not disclosed F1 · security: The options (the "Options") shall be issued on a basis requiring continued employment with the Company and the Company having achieved a minimum of $6 million in net revenues for the 2022 fiscal year. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with (i) 1/3 of the Options, priced at $1.32, vesting on December 31, 2022, (ii) 1/3 of the Options, priced at $1.58, vesting on December 31, 2023, and (iii) the final 1/3 of the Options, priced at $1.90, vesting on December 31, 2024. The restricted stock units do not expire, they either vest or are canceled prior to vesting date. F1 · derivative.exercise_price: The options (the "Options") shall be issued on a basis requiring continued employment with the Company and the Company having achieved a minimum of $6 million in net revenues for the 2022 fiscal year. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with (i) 1/3 of the Options, priced at $1.32, vesting on December 31, 2022, (ii) 1/3 of the Options, priced at $1.58, vesting on December 31, 2023, and (iii) the final 1/3 of the Options, priced at $1.90, vesting on December 31, 2024. The restricted stock units do not expire, they either vest or are canceled prior to vesting date. F1 · derivative.exercise_date: The options (the "Options") shall be issued on a basis requiring continued employment with the Company and the Company having achieved a minimum of $6 million in net revenues for the 2022 fiscal year. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with (i) 1/3 of the Options, priced at $1.32, vesting on December 31, 2022, (ii) 1/3 of the Options, priced at $1.58, vesting on December 31, 2023, and (iii) the final 1/3 of the Options, priced at $1.90, vesting on December 31, 2024. The restricted stock units do not expire, they either vest or are canceled prior to vesting date. F1 · derivative.expiration_date: The options (the "Options") shall be issued on a basis requiring continued employment with the Company and the Company having achieved a minimum of $6 million in net revenues for the 2022 fiscal year. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with (i) 1/3 of the Options, priced at $1.32, vesting on December 31, 2022, (ii) 1/3 of the Options, priced at $1.58, vesting on December 31, 2023, and (iii) the final 1/3 of the Options, priced at $1.90, vesting on December 31, 2024. The restricted stock units do not expire, they either vest or are canceled prior to vesting date. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 01:47 UTC | Creatd, Inc. CRTD · Entity 8175 | GrantStock Options · Derivative | 195,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-031256 · ownership.xml · derivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Underlying: Common Stock · 195,000 shares Expires not disclosed F1 · security: The Options ("Tranche 1 Options") shall be with a 30-day VWAP for the 30-day period. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with the Company with (i) 1/3 of the Tranche 1 Options vesting immediately upon the Company's shareholders' approval of the Creatd, Inc. 2022 Omnibus Securities and Incentive Plan, (ii) 1/3 of the Tranche 1 Options vesting on the first anniversary of the date hereof, and (iii) the final 1/3 of the Tranche 1 Options vesting on the second anniversary. The restricted stock units do not expire, they either vest or are canceled prior to vesting date. F1 · derivative.exercise_price: The Options ("Tranche 1 Options") shall be with a 30-day VWAP for the 30-day period. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with the Company with (i) 1/3 of the Tranche 1 Options vesting immediately upon the Company's shareholders' approval of the Creatd, Inc. 2022 Omnibus Securities and Incentive Plan, (ii) 1/3 of the Tranche 1 Options vesting on the first anniversary of the date hereof, and (iii) the final 1/3 of the Tranche 1 Options vesting on the second anniversary. The restricted stock units do not expire, they either vest or are canceled prior to vesting date. F1 · derivative.exercise_date: The Options ("Tranche 1 Options") shall be with a 30-day VWAP for the 30-day period. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with the Company with (i) 1/3 of the Tranche 1 Options vesting immediately upon the Company's shareholders' approval of the Creatd, Inc. 2022 Omnibus Securities and Incentive Plan, (ii) 1/3 of the Tranche 1 Options vesting on the first anniversary of the date hereof, and (iii) the final 1/3 of the Tranche 1 Options vesting on the second anniversary. The restricted stock units do not expire, they either vest or are canceled prior to vesting date. F1 · derivative.expiration_date: The Options ("Tranche 1 Options") shall be with a 30-day VWAP for the 30-day period. Each restricted Option represents a contingent right to receive one share of the Company's common stock. The Option will be issued and shall vest subject only to continued employment with the Company with (i) 1/3 of the Tranche 1 Options vesting immediately upon the Company's shareholders' approval of the Creatd, Inc. 2022 Omnibus Securities and Incentive Plan, (ii) 1/3 of the Tranche 1 Options vesting on the first anniversary of the date hereof, and (iii) the final 1/3 of the Tranche 1 Options vesting on the second anniversary. The restricted stock units do not expire, they either vest or are canceled prior to vesting date. Read SEC document |
| April 06, 2022 Filed Apr 9, 2022 01:46 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseOptions to purchase shares of Common Stock · Derivative | 121,000 | $0.01 Strike: $1.75 | $1,210.00 |
DisclosureSEC source: 0001213900-22-019070 · ownership.xml · derivative · entry 2 Weisberg Laurie · CIK 0001820954 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,000 Underlying: Common Stock · 121,000 shares Expires 2027-04-06 F1 · security: The stock options for 121,000 shares of the Company's common stock shall vest immediately. Read SEC document |
| April 06, 2022 Filed Apr 9, 2022 01:46 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock, par value $0.001 per share | 50,000 | $0.00 | $50.00 |
DisclosureSEC source: 0001213900-22-019070 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,249 Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 14:36 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock Purchase Warrant · Derivative | 5,714 | $0.01 Strike: $1.75 | $57.14 |
DisclosureSEC source: 0001213900-22-011470 · ownership.xml · derivative · entry 2 Weisberg Laurie · CIK 0001820954 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,285 Underlying: Common Stock · 5,714 shares Expires 2022-03-09 Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 14:36 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock, par value $0.001 per share | 5,714 | $1.74 | $9,942.36 |
DisclosureSEC source: 0001213900-22-011470 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,249 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 20:00 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock Purchase Warrant · Derivative | 28,571 | $0.01 Strike: $1.75 | $285.71 |
DisclosureSEC source: 0001213900-22-010552 · ownership.xml · derivative · entry 2 Weisberg Laurie · CIK 0001820954 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,571 Underlying: Common Stock · 28,571 shares Expires 2027-03-01 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 20:00 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock, par value $0.001 per share | 28,571 | $1.75 | $49,999.25 |
DisclosureSEC source: 0001213900-22-010552 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,535 Read SEC document |
| January 24, 2022 Filed Jan 24, 2022 21:45 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock | 2,000 | $1.68 | $3,360.00 |
DisclosureSEC source: 0001213900-22-003348 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,964 Read SEC document |
| January 10, 2022 Filed Jan 11, 2022 19:37 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock | 3,000 | $2.13 | $6,390.00 |
DisclosureSEC source: 0001213900-22-001520 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,964 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 13:31 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock | 4,000 | $2.40 | $9,600.00 |
DisclosureSEC source: 0001213900-21-061761 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,964 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 01:58 UTC | Creatd, Inc. CRTD · Entity 8175 | GrantOptions to purchase Common Stock · Derivative | 121,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-21-055952 · ownership.xml · derivative · entry 2 Weisberg Laurie · CIK 0001820954 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,000 Underlying: Common Stock · 121,000 shares Expires not disclosed F1 · shares: The Options were issued to Mr. Frommer pursuant to compensation arrangements recommended, approved and authorized by of the Compensation Committee of the Board of Directors of the Issuer. F1 · price: The Options were issued to Mr. Frommer pursuant to compensation arrangements recommended, approved and authorized by of the Compensation Committee of the Board of Directors of the Issuer. F2 · derivative.exercise_date: The options shall vest upon the achievement of certain metrics during the 2022 fiscal year, to be set by the Board not later than December 31, 2021. F3 · derivative.expiration_date: The expiration date for the options shall be set by the Board not later than December 31, 2021. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 01:58 UTC | Creatd, Inc. CRTD · Entity 8175 | GrantOptions to purchase Common Stock · Derivative | 121,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-21-055952 · ownership.xml · derivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,000 Underlying: Common Stock · 121,000 shares Expires 2026-10-29 F1 · shares: The Options were issued to Mr. Frommer pursuant to compensation arrangements recommended, approved and authorized by of the Compensation Committee of the Board of Directors of the Issuer. F1 · price: The Options were issued to Mr. Frommer pursuant to compensation arrangements recommended, approved and authorized by of the Compensation Committee of the Board of Directors of the Issuer. Read SEC document |
| October 12, 2021 Filed Oct 13, 2021 19:53 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock | 900 | $2.18 | $1,962.00 |
DisclosureSEC source: 0001213900-21-052624 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,964 Read SEC document |
| September 22, 2021 Filed Sep 23, 2021 17:31 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock | 1,000 | $3.11 | $3,110.00 |
DisclosureSEC source: 0001213900-21-049503 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,064 Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 12:32 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock | 2,000 | $2.97 | $5,940.00 |
DisclosureSEC source: 0001213900-21-043554 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,064 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:12 UTC | Creatd, Inc. CRTD · Entity 8175 | GrantOptions to purchase Common Stock · Derivative | 50,000 | $0.00 Strike: $5.65 | $0.00 |
DisclosureSEC source: 0001213900-21-011633 · ownership.xml · derivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock, par value $0.001 · 50,000 shares Expires 2026-02-23 F1 · shares: 25,000 stock options shall vest on February 23, 2022, and 25,000 stock options shall vest on February 23, 2023 F1 · derivative.exercise_date: 25,000 stock options shall vest on February 23, 2022, and 25,000 stock options shall vest on February 23, 2023 Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 21:54 UTC | Creatd, Inc. CRTD · Entity 8175 | PurchaseCommon Stock | 3,000 | $3.54 | $10,620.00 |
DisclosureSEC source: 0001213900-20-042278 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,064 Read SEC document |
| September 15, 2020 Filed Oct 6, 2020 01:50 UTC | Creatd, Inc. CRTD · Entity 8175 | ConversionConvertible Note · Derivative | Not disclosed | Not disclosed | $50,000.00 |
DisclosureSEC source: 0001213900-20-030192 · ownership.xml · derivative · entry 3 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,064 shares Expires 2021-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The lesser of $15 or 80% of the Uplist Pricing. F2 · price: This Note was converted into shares of common stock, as reported in Table I. Read SEC document |
| September 15, 2020 Filed Oct 6, 2020 01:50 UTC | Creatd, Inc. CRTD · Entity 8175 | ConversionCommon Stock | 14,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-20-030192 · ownership.xml · nonDerivative · entry 1 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The lesser of $15 or 80% of the Uplist Pricing. Read SEC document |
| July 31, 2020 Filed Oct 6, 2020 01:50 UTC | Creatd, Inc. CRTD · Entity 8175 | GrantConvertible Note · Derivative | Not disclosed | Not disclosed | $50,000.00 |
DisclosureSEC source: 0001213900-20-030192 · ownership.xml · derivative · entry 2 Weisberg Laurie · CIK 0001820954 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,064 Underlying: Common Stock · 14,064 shares Expires 2021-01-27 F1 · derivative.exercise_price: The lesser of $15 or 80% of the Uplist Pricing. F1 · price: The lesser of $15 or 80% of the Uplist Pricing. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.